IL6 and age-related macular degeneration: Both IL-6 and IRAK1 have been proposed as potential targets ofMIR146A, which thereby may be able to control the activation of NF-kb pathway and the related immune/inflammatory responses occurring in ageing processes and age-related disorders, including AMD [18,19].